![]() |
市场调查报告书
商品编码
1671988
益智药市场按形式、通路和地区划分Nootropics Market, By Form (Capsules/Tablets, Powder, Drinks, and Others), By Distribution Channel (Offline and Online), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) |
2025 年全球益智药市场规模估计为 41.7 亿美元,预计到 2032 年将达到 103.7 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 13.9%。
报告范围 | 报告详细信息 | ||
---|---|---|---|
基准年 | 2024 | 2025 年市场规模 | 41.7亿美元 |
效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
预测期:2025-2032年复合年增长率: | 13.90% | 2032 年价值预测 | 103.7亿美元 |
过去几年,随着人们对增强认知功能的补充剂的认识不断提高,全球益智药市场一直在稳步增长。益智药,也称为智慧药物,是一种旨在改善大脑功能和促进神经可塑性的物质。人们对认知能力和心理健康的关注度不断提高,促使许多人开始寻找自然和替代的方法来增强大脑功能。此外,忙碌的生活方式和日益增加的工作量也带来了对认知支持的需求,尤其是对专业人士而言。因此,含有 L-茶氨酸、咖啡因、过长沙马齿苋和丝胺酸等化合物的益智补充剂在世界各地获得了广泛支持。此外,老年人口的不断增长,更容易患神经退化性疾病,这可能在未来几年继续增加对益智药的需求。
全球益智药市场受到日益增长的健康和保健趋势、忙碌的生活方式以及对认知表现的日益关注的推动。然而,缺乏临床证据、严格的法规以及某些化合物的潜在副作用限制了市场的成长。人口老化的活性化和研发活动的增加将为市场提供重大机会。压力、焦虑和忧郁症导致的精神健康问题的增加推动了对支持大脑健康的补充剂的需求。此外,输送系统的进步和新化合物的引入进一步扩大了市场范围。然而,剂量和与其他药物相互作用的模糊性带来了重大挑战。
本研究的主要特点
本报告对全球益智药市场进行了详细分析,并提供了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%),假设基准年为 2024 年。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数,对全球益智药市场的主要企业进行了概述。
主要公司包括 Onnit Labs, Inc.、Qualia (Neurohacker Collective)、Nootrobox、Mind Lab Pro、Alpha Brain、Genius Consciousness、HVMN、Nootropics Depot、Neurohacker Collective、Clevor、BrainMD、Herbalife Nutrition Ltd.、NOW Foods、Gaia Herbs 和 Prometh制。
本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球益智药市场所使用的各种策略矩阵来简化决策。
Global Nootropics Market is estimated to be valued at US$ 4.17 Bn in 2025 and is expected to reach US$ 10.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | US$ 4.17 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 13.90% | 2032 Value Projection: | US$ 10.37 Bn |
The global nootropics market has been witnessing steady growth over the past few years owing to the increasing awareness about cognitive enhancing supplements. Nootropics, also known as smart drugs, are substances that are designed to improve brain function and promote neuroplasticity. The rising focus on cognitive abilities and mental health has prompted many individuals to look for natural and alternative methods of brain enhancement. Moreover, busy lifestyles and increasing workload have necessitated cognitive support, especially among professionals. As a result, nootropics supplements containing compounds such as L-theanine, caffeine, Bacopa monnieri, and phosphatidylserine are gaining significant traction globally. Furthermore, growing geriatric population susceptible to neurodegenerative disorders will continue bolstering the demand for nootropics in the upcoming years.
The global nootropics market is driven by rising health consciousness, busy lifestyles, and increased focus on cognitive abilities. However, lack of clinical evidence, stringent regulations, and potential side effects of certain compounds are limiting the market growth. Growing aging population and increased research & development activities present tremendous opportunities in the market. Rising mental health issues due to stress, anxiety, and depression have enhanced the demand for supplements supporting brain health. Additionally, advancements in delivery systems and introduction of newer compounds are further expanding the scope of the market. However, ambiguity related to dosage levels and interaction with other drugs are major challenges.
Key Features of the Study
This report provides in-depth analysis of the global nootropics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nootropics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Onnit Labs, Inc., Qualia (Neurohacker Collective), Nootrobox, Mind Lab Pro, Alpha Brain, Genius Consciousness, HVMN, Nootropics Depot, Neurohacker Collective, Clevor, BrainMD, Herbalife Nutrition Ltd., NOW Foods, Gaia Herbs, and Prometheus
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nootropics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nootropics market